IDEXX LABORATORIES INC /DE Proceeds from Sale of Productive Assets
IDEXX LABORATORIES INC /DE (IDXX) reported Proceeds from Sale of Productive Assets of $3.38 million for the 12-month period ending 2009-12-31, per its 10-K filed 2011-02-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2011-02-22
- IDEXX LABORATORIES INC /DE proceeds from sale of productive assets for the quarter ending 2009-12-31 was $2.00M.
- IDEXX LABORATORIES INC /DE proceeds from sale of productive assets for the quarter ending 2009-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE proceeds from sale of productive assets for fiscal 2009 was $3.38M, a 51.93% decline from fiscal 2008.
- IDEXX LABORATORIES INC /DE proceeds from sale of productive assets for fiscal 2008 was $7.03M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2009-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22 | $2.00M derived: sum of 2 quarters · filed 2011-02-22 | $3.38M 10-K · filed 2011-02-22 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | $1.38M 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | $1.38M 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | $7.03M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |